PLA2G4A and colitis: COP ameliorated colitis in mice by regulating the cPLA2/TRPM8/CGRP-1 pathway, strengthening intestinal barrier function, and modulating inflammatory mediators, which was supported by network pharmacology analysis, offering novel insights into its protecting mechanism.